Cory B Pittman, MD in Des Moines, IA - Medicare Rheumatology

Cory B Pittman, MD is a medicare enrolled "Internal Medicine - Rheumatology" physician in Des Moines, Iowa. He went to University Of Missouri, Columbia School Of Medicine and graduated in 2002 and has 22 years of diverse experience with area of expertise as Rheumatology. He is a member of the group practice Iowa Arthritis And Osteoporosis Center Pc and his current practice location is 8421 Plum Dr, Des Moines, Iowa. You can reach out to his office (for appointments etc.) via phone at (515) 643-9699.

Cory B Pittman is licensed to practice in Iowa (license number 37072) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1285765354.

Contact Information

	Cory B Pittman, MD
	8421 Plum Dr, Des Moines, IA 50322-7356
	(515) 643-9699
	(515) 643-9698

Physician's Profile

Full Name	Cory B Pittman
Gender	Male
Speciality	Rheumatology
Experience	22 Years
Location	8421 Plum Dr, Des Moines, Iowa
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Cory B Pittman attended and graduated from University Of Missouri, Columbia School Of Medicine in 2002

NPI Data:

NPI Number: 1285765354
Provider Enumeration Date: 03/08/2007
Last Update Date: 08/05/2020

Medicare PECOS Information:

PECOS PAC ID: 9436253077
Enrollment ID: I20070409000418

Medical Identifiers

Medical identifiers for Cory B Pittman such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1285765354	NPI	-	NPPES
252763	Other	IA	MIDLANDS CHOICE
32380	Other	IA	WELLMARK BLUE SHIELD
0789909	Medicaid	IA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RR0500X	Internal Medicine - Rheumatology	37072 (Iowa)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Mercyone Des Moines Medical Center	Des moines, IA	Hospital
Trinity Regional Medical Center	Fort dodge, IA	Hospital
Pella Regional Health Center	Pella, IA	Hospital
Mercyone Centerville Medical Center	Centerville, IA	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Iowa Arthritis And Osteoporosis Center Pc	0941514715	17

News Archive

Research roundup: Closing E.R.S; Predicting future health costs; Providing rural residents with specialized care

Factors Associated With The Closures Of Emergency Departments In The United States - This study looks at the community, market and medical factors that led to an increase of urban hospital-based emergency department closures.

Novel therapeutic approach may be effective for disrupting bacterial biofilms

Biofilms are communities of bacteria that adhere to a surface and are nearly impossible to eradicate when they are pathogenic, or disease-causing.

FDA approves Cubist Pharmaceuticals' sNDA for ENTEREG

Cubist Pharmaceuticals, Inc. today announced the approval of its supplemental new drug application (sNDA) by the U.S. Food and Drug Administration for ENTEREG (alvimopan).

UC study explores how low risk stress reduction treatments may benefit epilepsy patients

Patients with epilepsy face many challenges, but perhaps the most difficult of all is the unpredictability of seizure occurrence. One of the most commonly reported triggers for seizures is stress.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Cory B Pittman allows following entities to bill medicare on his behalf.

Entity Name	Iowa Arthritis And Osteoporosis Center Pc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1720462914 PECOS PAC ID: 0941514715 Enrollment ID: O20150806012531

News Archive

Research roundup: Closing E.R.S; Predicting future health costs; Providing rural residents with specialized care

Novel therapeutic approach may be effective for disrupting bacterial biofilms

Biofilms are communities of bacteria that adhere to a surface and are nearly impossible to eradicate when they are pathogenic, or disease-causing.

FDA approves Cubist Pharmaceuticals' sNDA for ENTEREG

Cubist Pharmaceuticals, Inc. today announced the approval of its supplemental new drug application (sNDA) by the U.S. Food and Drug Administration for ENTEREG (alvimopan).

UC study explores how low risk stress reduction treatments may benefit epilepsy patients

Patients with epilepsy face many challenges, but perhaps the most difficult of all is the unpredictability of seizure occurrence. One of the most commonly reported triggers for seizures is stress.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Cory B Pittman is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Cory B Pittman, MD 8421 Plum Dr, Urbandale, IA 50322-7356 Ph: (515) 270-7222	Cory B Pittman, MD 8421 Plum Dr, Des Moines, IA 50322-7356 Ph: (515) 643-9699

News Archive

Research roundup: Closing E.R.S; Predicting future health costs; Providing rural residents with specialized care

Novel therapeutic approach may be effective for disrupting bacterial biofilms

Biofilms are communities of bacteria that adhere to a surface and are nearly impossible to eradicate when they are pathogenic, or disease-causing.

FDA approves Cubist Pharmaceuticals' sNDA for ENTEREG

Cubist Pharmaceuticals, Inc. today announced the approval of its supplemental new drug application (sNDA) by the U.S. Food and Drug Administration for ENTEREG (alvimopan).

UC study explores how low risk stress reduction treatments may benefit epilepsy patients

Patients with epilepsy face many challenges, but perhaps the most difficult of all is the unpredictability of seizure occurrence. One of the most commonly reported triggers for seizures is stress.

Internal Medicine Doctors in Des Moines, IA

Dr. Joshua C Lukenbill, D.O. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1221 Pleasant Street, Suite 100, Des Moines, IA 50309 Phone: 515-282-2921 Fax: 515-282-1035
Dr. Akshay Mahesh Khatri, M.B.B.S., MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1221 Pleasant St Ste 300, Des Moines, IA 50309 Phone: 515-241-4200 Fax: 515-241-4048
Ravinder Dervesh, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 411 Laurel St Ste 1225, Des Moines, IA 50314 Phone: 515-633-3770 Fax: 515-288-6713
Mr. David Augusto Terrero Salcedo, M.D Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1221 Pleasant St Ste 300, Des Moines, IA 50309 Phone: 515-241-4200 Fax: 515-241-4048
Tyler Mumm, DO Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1111 6th Ave, Des Moines, IA 50314 Phone: 515-643-2261 Fax: 515-643-5802
Bilal Hasan Baig, DO Rheumatology Medicare: Medicare Enrolled Practice Location: 1200 Pleasant St, Des Moines, IA 50309 Phone: 515-241-6636 Fax: 515-241-4080
Dr. Sean D Cunningham, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1215 Pleasant St, Ste 206, Des Moines, IA 50309 Phone: 515-875-9092 Fax: 515-875-9828

Cory B Pittman, MD - Medicare Rheumatology in Des Moines, IA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Research roundup: Closing E.R.S; Predicting future health costs; Providing rural residents with specialized care

Novel therapeutic approach may be effective for disrupting bacterial biofilms

FDA approves Cubist Pharmaceuticals' sNDA for ENTEREG

UC study explores how low risk stress reduction treatments may benefit epilepsy patients

Medicare Reassignments

Research roundup: Closing E.R.S; Predicting future health costs; Providing rural residents with specialized care

Novel therapeutic approach may be effective for disrupting bacterial biofilms

FDA approves Cubist Pharmaceuticals' sNDA for ENTEREG

UC study explores how low risk stress reduction treatments may benefit epilepsy patients

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Research roundup: Closing E.R.S; Predicting future health costs; Providing rural residents with specialized care

Novel therapeutic approach may be effective for disrupting bacterial biofilms

FDA approves Cubist Pharmaceuticals' sNDA for ENTEREG

UC study explores how low risk stress reduction treatments may benefit epilepsy patients

Internal Medicine Doctors in Des Moines, IA